Kindstar Globalgene Technology (HKG:9960) and its unit agreed to acquire two companies for a total of $31.3 million on Sept. 20, a same-day bourse filing said.
Kindstar Globalgene Technology will buy AnchorDx from AnchorDx Group HK. Unit Kindstar Global Medical Technology (Wuhan) will also purchase Guangzhou Kangcheng Weiye Biotechnology from AnchorDx Group HK and six other sellers.
The company will fulfill the consideration for the acquisitions with cash payments and the allotment and issue of consideration shares.
Shares of the clinical testing company closed over 2% higher on Monday.
Price (HKD): $1.25, Change: $+0.030, Percent Change: +2.46%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.